Imagin Medical (FRA:DPD3) Cyclically Adjusted PB Ratio: (As of Jul. 20, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Imagin Medical Cyclically Adjusted PB Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


Imagin Medical  (FRA:DPD3) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


Imagin Medical Cyclically Adjusted PB Ratio Related Terms


Imagin Medical Cyclically Adjusted PB Ratio Historical Data

* Premium members only.

The historical data trend for Imagin Medical's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Imagin Medical Cyclically Adjusted PB Ratio Chart

Imagin Medical Annual Data
Trend Sep13 Sep14 Sep15 Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.26 0.11 0.07 0.10 0.12

Imagin Medical Quarterly Data
Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.06 0.12 0.12 0.16 0.00

FRA:DPD3 vs ABT, SYK, MDT: Cyclically Adjusted PB Ratio Comparison

For the Medical Devices subindustry, Imagin Medical's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Imagin Medical Cyclically Adjusted PB Ratio vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Imagin Medical's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Imagin Medical's Cyclically Adjusted PB Ratio falls into.



Imagin Medical Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

Imagin Medical's Cyclically Adjusted Book per Share for the quarter that ended in Jun. 2023 is calculated as:

For example, Imagin Medical's adjusted Book Value per Share data for the three months ended in Jun. 2023 was:

Adj_Book=Book Value per Share/CPI of Jun. 2023 (Change)*Current CPI (Jun. 2023)
=-0.767/124.2033*124.2033
=-0.767

Current CPI (Jun. 2023) = 124.2033.

Imagin Medical Quarterly Data

Book Value per Share CPI Adj_Book
201309 8.330 97.419 10.620
201312 7.582 96.945 9.714
201403 6.861 98.604 8.642
201406 5.737 99.473 7.163
201409 0.825 99.394 1.031
201412 0.438 98.367 0.553
201503 0.077 99.789 0.096
201506 -0.232 100.500 -0.287
201509 -0.036 100.421 -0.045
201512 -0.050 99.947 -0.062
201603 0.293 101.054 0.360
201606 0.158 102.002 0.192
201609 0.042 101.765 0.051
201612 0.054 101.449 0.066
201703 -0.054 102.634 -0.065
201706 -0.125 103.029 -0.151
201709 -0.139 103.345 -0.167
201712 0.278 103.345 0.334
201803 0.452 105.004 0.535
201806 0.700 105.557 0.824
201809 0.589 105.636 0.693
201812 0.518 105.399 0.610
201903 0.436 106.979 0.506
201906 0.328 107.690 0.378
201909 0.208 107.611 0.240
201912 0.086 107.769 0.099
202003 0.065 107.927 0.075
202006 0.026 108.401 0.030
202009 -0.024 108.164 -0.028
202012 -0.062 108.559 -0.071
202103 -0.225 110.298 -0.253
202106 -0.256 111.720 -0.285
202109 -0.836 112.905 -0.920
202112 -0.864 113.774 -0.943
202203 -0.979 117.646 -1.034
202206 -0.659 120.806 -0.678
202209 -0.932 120.648 -0.959
202212 -0.854 120.964 -0.877
202303 -0.893 122.702 -0.904
202306 -0.767 124.203 -0.767

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Imagin Medical Business Description

Address 890 West Pender Street, Suite 600, Vancouver, BC, CAN, V6C 1J9
Imagin Medical Inc is a Urologic Oncology company developing technologies to visualize and treat urologic cancers, including bladder and prostate cancer, through minimally invasive surgery. The company's first product, the i/Blue Imaging System, with its proprietary optics and light sensors, will greatly increase the efficiency and accuracy of detecting bladder cancer, helping to improve the surgical management of this disease. Imagin's follow-on product, the enCAGE Coil is a device with 510(k) clearance for soft tissue ablation. Imagin intends to refine the disposable bipolar radio frequency-based probe for use in the treatment of prostate cancer and benign prostate hypoplasia (BPH) and submit appropriate FDA premarket applications for the new indications.